An Ebola drug used to treat two infected Americans was developed by a Winston-Salem-based Reynolds American subsidiary, according to Bloomberg.
A limited amount of the drug, dubbed ZMapp, was sent last week from Kentucky BioProcessing LLC, a subsidiary of Reynolds American Inc. which makes the treatment from tobacco plants, to treat Kent Brantly, of Texas and Indiana, and Nancy Writebol, of North Carolina.
Brantly and Writebol became infected while working with aid groups in Liberia.
Brantly, a doctor, arrived in Atlanta on Aug. 2 and is under treatment at Emory University Hospital. Writebol, an aid worker, arrived in Atlanta Tuesday and will be treated at the same hospital.